Heidi Health
PrivateLast Round
Growth Equity
Sep 22, 2026
Est. Valuation
$900M
Total Funding Raised
$432.9M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Heidi Health operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Growth Equity round in September 2026.
Heidi Health is a healthcare technology company that provides an AI-powered platform for clinicians to transcribe patient consultations, generate structured medical notes, and streamline clinical workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Workflow Automation, EHR & EMR, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Heidi Health Comparables
Compare Heidi Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suki | 90% | |
| Abridge Inc | 87% | |
| Ambience Healthcare | 86% |
For institutional investors. Book with your work email.
Heidi Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Sep 22, 2026 | ||||
| Series C | Sep 22, 2026 | ||||
| Series B | Oct 6, 2025 | ||||
| Series A Extension | Mar 4, 2025 | ||||
| Series A | Oct 26, 2023 | ||||
Seed | Aug 24, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Heidi Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Goodwater Capital | Series B |
| LocalGlobe | Series A Extension |
| General Catalyst's Customer Value Fund | Growth Equity, Series C |
| Hostplus Superannuation Fund | Series A |
| LG Technology Ventures | Series B |
| Point72 Private Investments | Series C, Series B |
| Phoenix Court Group | Series C, Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2026
Signed MOU with Samsung Medical Center for first South Korean collaboration.
- Nov 6, 2026
Named AI Innovator at the Startup Daily awards.
For institutional investors. Book with your work email.
Heidi Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Heidi Health's valuation, stock price, and market status.
Is Heidi Health a public or private company?
Heidi Health is a private company.
What is the current stock price of Heidi Health?
Heidi Health is a private company, so its shares have no public market price. Caplight tracks Heidi Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Heidi Health worth (valuation)?
Heidi Health's valuation is estimated at $900.0M based on funding round data.
Can I buy Heidi Health stock?
Heidi Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Heidi Health's last funding round?
Heidi Health's most recent funding round was Growth Equity on September 22, 2026.
Who are the main investors in Heidi Health?
Key investors in Heidi Health include General Catalyst's Customer Value Fund, Point72 Private Investments, Headline, Blackbird Ventures.
Will Heidi Health IPO soon?
No public IPO plans have been announced for Heidi Health.
How can I track Heidi Health secondary market activity?
Caplight tracks bids, offers, and trades in Heidi Health's shares on secondary markets.